JAG1 and neoplasm: In addition, immune cells may drive Notch signaling at the edge of the tumor, as for breast cancers, where the stimulation of JAG1/NOTCH interactions by cytokine like IL-6 triggers a partial mesenchymal phenotype and an increase in stem-like characteristics (Bocci et al., 2019).